RECALL DATABASE

NAD+ Injection Recall: Apothecary 200 mg/mL vial

Announced 2026-10-14 · FDA

Apothecary NAD+ Injection 200 mg/mL, 6 mL sterile multi-dose vial, Rx Only, is being recalled nationwide due to lack of assurance of sterility. The recall involves lot AP-202647 with a BUD of 13-Oct-2026.

BrandApothecary Pharma LLC
ProductApothecary NAD+ Injection 200 mg/mL, 6 mL Sterile Multi-Dose Vial, Rx Only, Apothecary Pharma, LLC, 1913 Evans Road, Cary, NC, 27513, NDC 85091-011-06.
ReasonLack of Assurance of Sterility
Severitymoderate
Units affected22
DistributionNationwide within the United States
AgencyFDA

WHAT YOU SHOULD DO

  1. Do not use the recalled NAD+ Injection if you have it.
  2. Check your vials for lot AP-202647 and confirm the BUD date of 13-Oct-2026; set affected product aside.
  3. Contact your healthcare provider or the recalling entity for guidance on return, disposal, or replacement.

How to identify the recalled item

Lot / date codesLot #: AP-202647, BUD 13-Oct-2026
Lot / date codesLot #: AP-202622, BUD 07-Oct-2026; AP-202623, BUD 08-Oct-2026; AP-202624, BUD 19-Oct-2026; AP-202625, BUD 10/20/2026; AP-202627, BUD 10/26/2026; AP-202628, BUD 10/27/2026; AP-202629, BUD 10/28/2026; AP-202630, BUD 10/31/2026; AP-202631, BUD 11/01/2026; AP-202632, BUD 11/03/2026; AP-202633, BUD 11/07/2026; AP-202634, BUD 11/08/2026; AP-202635, BUD 11/16/2026; AP-202636, BUD 11/17/2026; AP-202637,BUD 11/18/2026; AP-202638, BUD 11/19/2026; AP-202639, BUD 11/20/2026; AP-202640, BUD 11/21/2026;AP-202641, BUD 11/22/2026; AP-202642, BUD 11/24/2026; AP-202643, BUD 11/25/2026; AP-202644, BUD 11/26/2026

These are the identifiers FDA published for this recall. Most recall notices list no UPC or model number at all — if the code on your item is not shown here, that does not mean the item is excluded. Check the official notice, or contact the company.

This is an automatically maintained record of an official recall notice. Details can change; always follow the official notice linked above. See all records in the Recall Database.